Information

TWB & DEINOVE optimize Deinococcus production

10 May 2016

DEINOVE and TWB undertake a collaborative R&D project to optimize the metabolic fluxes of Deinococcus. This partnership aims to strengthen DEINOVE’s unique expertise of Deinococcus metabolism and optimize the production of targeted compounds of interest. The project, conducted in collaboration with the MetaToul platform (LISBP, INSA Toulouse – MetaboHUB national infrastructure) headed by Prof. Jean-Charles… Read more »

EnobraQ raises funds

19 April 2016

EnobraQ, start-up from a TWB research project, that develops CO2-based industrial fermentation processes, announces it has secured a 2.9 M€ seed financing round. Sofinnova Partners, original investor, is joined by Auriga Partners, IRDInov and CEA Investissement. Proceeds will be allocated towards EnobraQ’s research and development plan targeting an advanced proof of concept before the end… Read more »

The 2015 activity report is published

2 March 2016

TWB published its 2015 activity report. The results confirm the attractiveness and the effectiveness of the mode of operation of TWB and of its associated research teams. Welcome of 10 new partners, entry into service of a unique microbial culture robotic platform, move into new premises doubling the reception capacity, quality certification ISO9001 and creation… Read more »

7 new industrial partners for TWB

10 February 2016

For the meeting of the Strategic Steering Committee on February 3 & 4, 2016, TWB welcomed the 7 new industrial partners of its consortium. These members noticed that TWB moved into a new phase of achievements when presenting the 2015 results. Seven new industrial partners joined the TWB consortium as of 1st January 2016, bringing to… Read more »

AIMBE: induction of Pierre Monsan to its College of Fellows

25 January 2016

The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Pierre Monsan, Ph.D., Founding Director of TWB, to its College of Fellows. Dr. Monsan was nominated, reviewed, and elected by peers and members of the College of Fellows for outstanding scientific and industrial contributions to the field of enzymatic carbohydrate… Read more »

TWB & AMOEBA: a major technological advance

19 January 2016

Within the framework of a R&D contract between TWB and AMOEBA, TWB teams have been able to optimize amoeba production, by knocking down major technological barriers: transposing the process from an adhesion culture to a continuous suspension culture, multiplying by 10 the final amoeba concentration, developing a stable and economically viable culture medium. TWB and… Read more »

TWB strengthens its activity in industry partnerships

3 September 2015

David Guerrand has joined TWB on September 1st, in charge of industry partnerships. David will work together with Michel Manach, Director of industry partnerships. This new resource will allow TWB to serve its development with a growing number of competitive contracts and industry partners joining TWB. David Guerrand holds a Ph D in biotechnology completed… Read more »

TWB supports the iGEM Toulouse 2015 project

17 July 2015

TWB provides financial support to the iGEM Toulouse 2015 team. The aim of the project is the development of a means of controlling Varroa, the first cause of parasite-induced mortality among honey bees in Europe and in the US, by using a biological pathway that is more advantageous and ecological than chemical products used so… Read more »

TWB and Hamilton develop a unique microbial culture robot

30 June 2015

TWB and Hamilton have collaborated for 18 months to develop an innovative bioprocessing platform for the in-depth characterization and culture optimization of microorganisms. This platform, with 24 integrated mini-bioreactors (50 mL), will significantly speed up the process to develop industrial bioprocess solutions for a wide range of applications in green chemistry (e.g. chemicals, enzymes, biopolymers,… Read more »

IBISBA Workshop: 25th June 2015

29 May 2015

IBISBA is a European research infrastructure for industrial biotechnology. It aims to bridge a gap by constructing a continuum between academic research and industry, by translating industrial and socioeconomic constraints into scientific and technical questions that can integrated into early stage biocatalyst design and bioprocess development. It is expected that IBISBA will provide a major… Read more »